{Reference Type}: Journal Article
{Title}: Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup.
{Author}: Ding J;Gong S;
{Journal}: Front Pharmacol
{Volume}: 15
{Issue}: 0
{Year}: 2024
{Factor}: 5.988
{DOI}: 10.3389/fphar.2024.1398879